Biolife Solutions Inc.
Preservation and storage of cellular and tissue-based systems
John G. Baust, Ph.D., CSO, Founder and Chairman
Michael Rice
John G. Baust
Howard Breslow
Roderick deGreef
Thomas Girschweiler
Raymond Cohen
171 Front Street
Owego, NY 13827-1520
USA
Phone: +1-866-4BIOLIFE
Fax: +1-607-687-6683
BioLife Solutions, Inc. is investigating abilities to preserve and store cells, tissues and organs in order to improve the quality of stored biological materials in terms of decontamination and function.
BioLife considers the role of apoptosis and necrosis in low-temperature systems that can be caused by free radical accumulation in cells as a central aspect of quality and function of life systems.
BioLife’s HypoThermosol® series (including GelStor™ which supports the storage and transportation of fragile tissues) is optimised for the storage of cells, tissues and organs. CryoStor™ products of cryopreservation media are used for the low-temperature preservation of many biological systems.
The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.
Related patents
- Inclusion of Apoptotic Regulators in Solutions for Cell Storage at Low Temperature
- Novel Techniques for the Preparation and Crystallization of 4-O-beta-D-Galactopyranosyl-D-gluconic Acid
- Normothermic, Hypothermic and Cryopreservation Maintenance and Storage of Cells, Tissues and Organs in Gel-based Media
- Storage of Cells, Tissues and Organs in Gel-based Media
- Normothermic, Hypothermic and Cryopreservation Maintenance and Storage of Cells, Tissues and Organs in Gel-based Media
- Method and Use of Protein Microarray Technology and Proteomic Analysis to Determine Efficacy of Human and Xenographic Cell, Tissue and Organ Transplant
- Methods and Compositions for the Preservation of Cells, Tissues or Organs in the Vitreous State